Journal of Biological Chemistry
Volume 295, Issue 21, 22 May 2020, Pages 7179-7192
Editors' PicksEnhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine
Under a Creative Commons license
open access
hepatitis C virus (HCV)
vaccine development
glycoprotein
disulfide
immunogenicity
antigen engineering
broadly neutralizing antibody (bNAb)
D123-HMW
multimerization
protein refolding
Cited by (0)
This study was supported by National Health and Medical Research Council Grants GNT1041897, GNT1146082, and GNT1080045 and the Australian Centre for HIV and Hepatitis Virology. The authors declare that they have no conflicts of interest with the contents of this article.
This article was selected as one of our Editors' Picks.
This article contains Table S1 and Figs. S1–S4.
© 2020 Center et al.